Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 35Recruiting 24Terminated 11Unknown 9Not yet recruiting 6Active not recruiting 6Withdrawn 3

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 27Carcinoma, Non-Small-Cell Lung 15Neoplasms 6Lung Neoplasms 6Cholangiocarcinoma 6Carcinoma, Hepatocellular 5Sarcoma 4Neoplasm Metastasis 4Bone Neoplasms 4Recurrence 3Ovarian Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Histiocytoma, Malignant Fibrous 3Dermatofibrosarcoma 3Biliary Tract Neoplasms 3Adenocarcinoma 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Sarcoma, Synovial 2Rhabdomyosarcoma 2Neoplasms, Unknown Primary 2Lymphoma, T-Cell 2Lymphoma, B-Cell 2Liposarcoma 2Leiomyosarcoma 2Hodgkin Disease 2Hemangiosarcoma 2Gallbladder Neoplasms 2Fallopian Tube Neoplasms 2

Interventions

Gemcitabine 3Cisplatin 3Irinotecan 2Fluorouracil 2Capecitabine 2tremelimumab 1pamiparib 1durvalumab 1brigimadlin 1atezolizumab 1Temozolomide 1Surgical Procedures, Operative 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Leucovorin 1IMC-001 1Blood Specimen Collection 1ARX788 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Biliary Tract Neoplasms × Gemcitabine × Clear all
NCT06017297 2024-11-12

ESR-22-21719

Georgetown University

Phase 2 Withdrawn
Gastrointestinal

Biliary Tract Neoplasms

NCT04796454 2022-06-01

PAMICC

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Withdrawn
Gastrointestinal

Biliary Tract Neoplasms

NCT04480190 2022-04-20

Neoadjuvant Therapy in Biliary Adenocarcinoma

University of Cincinnati

Phase 1 Withdrawn
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡